{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:25:10Z","timestamp":1790220310432,"version":"4.1.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008572","name":"University of Ottawa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008572","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.mcna.2025.01.008","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T21:46:30Z","timestamp":1744494390000},"page":"907-921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Thrombophilia Testing in Venous Thromboembolism"],"prefix":"10.1016","volume":"109","author":[{"given":"Kristina","family":"Vrotniakaite-Bajerciene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Angelillo-Scherrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana A.","family":"Castellucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.mcna.2025.01.008_bib1","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrcardio.2015.83","article-title":"Epidemiology of venous thromboembolism","volume":"12","author":"Heit","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.mcna.2025.01.008_bib2","series-title":"Gesammelte Abhandlungen zur wissenschaftlichen Medizin","author":"Virchow","year":"1856"},{"issue":"1","key":"10.1016\/j.mcna.2025.01.008_bib3","first-page":"59","article-title":"Thrombophilia as a multigenic disease","volume":"84","author":"Z\u00f6ller","year":"1999","journal-title":"Haematologica"},{"issue":"21","key":"10.1016\/j.mcna.2025.01.008_bib4","doi-asserted-by":"crossref","first-page":"6717","DOI":"10.1182\/bloodadvances.2023010027","article-title":"Crucial roles of red blood cells and platelets in whole blood thrombin generation","volume":"7","author":"Sun","year":"2023","journal-title":"Blood Advances"},{"key":"10.1016\/j.mcna.2025.01.008_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.918775","article-title":"Coagulation and complement: key innate defense participants in a seamless web","volume":"13","author":"Pryzdial","year":"2022","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.mcna.2025.01.008_bib6","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1055\/s-0036-1592333","article-title":"Environmental and genetic risk factors associated with venous thromboembolism","volume":"42","author":"Crous-Bou","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"10.1016\/j.mcna.2025.01.008_bib7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1182\/hematology.2023000491","article-title":"The dos, don\u2019ts, and nuances of thrombophilia testing","volume":"2023","author":"Chiasakul","year":"2023","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"12","key":"10.1016\/j.mcna.2025.01.008_bib8","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMra1700365","article-title":"Thrombophilia testing and venous thrombosis","volume":"377","author":"Connors","year":"2017","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.mcna.2025.01.008_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11144188","article-title":"Thrombophilia impact on treatment decisions, subsequent venous or arterial thrombosis and pregnancy-related morbidity: a retrospective single-center cohort study","volume":"11","author":"Vrotniakaite-Bajerciene","year":"2022","journal-title":"J Clin Med"},{"issue":"S1","key":"10.1016\/j.mcna.2025.01.008_bib10","first-page":"104","article-title":"Optimal utilization of thrombophilia testing","volume":"39","author":"Pruthi","year":"2017","journal-title":"Int J Lit Humanit"},{"issue":"22","key":"10.1016\/j.mcna.2025.01.008_bib11","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1182\/bloodadvances.2023010177","article-title":"American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing","volume":"7","author":"Middeldorp","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.mcna.2025.01.008_bib12","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/bjh.18239","article-title":"Thrombophilia testing: a British society for haematology guideline","author":"Arachchillage","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.mcna.2025.01.008_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.thromres.2022.12.001","article-title":"Adherence to thrombophilia testing guidelines and its influence on anticoagulation therapy: a single-center cross-sectional study","volume":"223","author":"Vrotniakaite-Bajerciene","year":"2023","journal-title":"Thromb Res"},{"issue":"5","key":"10.1016\/j.mcna.2025.01.008_bib14","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/jth.13284","article-title":"Clinical adherence to thrombophilia screening guidelines at a major tertiary care hospital","volume":"14","author":"Kwon","year":"2016","journal-title":"J Thromb Haemostasis"},{"issue":"6475","key":"10.1016\/j.mcna.2025.01.008_bib15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.mcna.2025.01.008_bib16","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1073\/pnas.91.4.1396","article-title":"Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V","volume":"91","author":"Dahlb\u00e4ck","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.mcna.2025.01.008_bib17","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1160\/TH07-02-0150","article-title":"Coagulation factor V and thrombophilia: background and mechanisms","volume":"98","author":"Segers","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.mcna.2025.01.008_bib18","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1538-7836.2012.04656.x","article-title":"Role of factor V Leiden or G20210A prothrombin mutation in patients with symptomatic pulmonary embolism and deep vein thrombosis: a meta-analysis of the literature","author":"Dentali","year":"2012","journal-title":"J Thromb Haemostasis"},{"issue":"4","key":"10.1016\/j.mcna.2025.01.008_bib19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/s-2007-996025","article-title":"Epidemiology of factor V Leiden: clinical implications","volume":"24","author":"De Stefano","year":"1998","journal-title":"Semin Thromb Hemost"},{"issue":"10","key":"10.1016\/j.mcna.2025.01.008_bib20","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","article-title":"A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis","volume":"88","author":"Poort","year":"1996","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.mcna.2025.01.008_bib21","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1538-7836.2010.03773.x","article-title":"Prothrombin G20210A carriers the genetic mutation and a history of venous thrombosis contributes to thrombin generation independently of factor II plasma levels","volume":"8","author":"Lavigne-Lissalde","year":"2010","journal-title":"J Thromb Haemostasis"},{"issue":"4","key":"10.1016\/j.mcna.2025.01.008_bib22","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1055\/s-0037-1615049","article-title":"Geographic distribution of the 20210 G to A prothrombin variant","volume":"79","author":"Rosendaal","year":"1998","journal-title":"Thromb Haemost"},{"issue":"23","key":"10.1016\/j.mcna.2025.01.008_bib23","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1182\/blood.2023023326","article-title":"Thrombosis risk in single- and double-heterozygous carriers of factor V Leiden and prothrombin G20210A in FinnGen and the UK Biobank","volume":"143","author":"Ryu","year":"2024","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.mcna.2025.01.008_bib24","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1160\/th15-05-0391","article-title":"PROS1 genotype phenotype relationships in a large cohort of adults with suspicion of inherited quantitative protein S deficiency","volume":"115","author":"Alhenc-Gelas","year":"2016","journal-title":"Thromb Haemost"},{"issue":"9","key":"10.1016\/j.mcna.2025.01.008_bib25","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1055\/s-0040-1714100","article-title":"Genotype-phenotype relationships in a large French cohort of subjects with inherited protein C deficiency","volume":"120","author":"Alhenc-Gelas","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.mcna.2025.01.008_bib26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.thromres.2019.01.022","article-title":"SERPINC1 variants causing hereditary antithrombin deficiency in a Danish population","volume":"175","author":"Kjaergaard","year":"2019","journal-title":"Thromb Res"},{"issue":"5","key":"10.1016\/j.mcna.2025.01.008_bib27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MOH.0000000000000663","article-title":"Protein S: function, regulation, and clinical perspectives","volume":"28","author":"Majumder","year":"2021","journal-title":"Curr Opin Hematol"},{"issue":"6","key":"10.1016\/j.mcna.2025.01.008_bib28","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1160\/TH11-08-0522","article-title":"The structure-function relationship of activated protein C. Lessons from natural and engineered mutations","volume":"106","author":"Wildhagen","year":"2011","journal-title":"Thromb Haemost"},{"issue":"12","key":"10.1016\/j.mcna.2025.01.008_bib29","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1111\/jth.15052","article-title":"Anticoagulant and signaling functions of antithrombin","volume":"18","author":"Rezaie","year":"2020","journal-title":"J Thromb Haemostasis"},{"issue":"4","key":"10.1016\/j.mcna.2025.01.008_bib30","doi-asserted-by":"crossref","first-page":"e023018","DOI":"10.1161\/JAHA.121.023018","article-title":"Classic thrombophilias and thrombotic risk among middle-aged and older adults: a population-based cohort study","volume":"11","author":"Manderstedt","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.mcna.2025.01.008_bib31","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1160\/TH15-04-0330","article-title":"Ethnic diversity in the genetics of venous thromboembolism","volume":"114","author":"Tang","year":"2015","journal-title":"Thromb Haemost"},{"issue":"7","key":"10.1016\/j.mcna.2025.01.008_bib32","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1111\/jth.15732","article-title":"Diagnosis and management of severe congenital protein C deficiency (SCPCD): communication from the SSC of the ISTH","volume":"20","author":"Minford","year":"2022","journal-title":"J Thromb Haemostasis"},{"issue":"1","key":"10.1016\/j.mcna.2025.01.008_bib33","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/jth.15109","article-title":"Recommendations for clinical laboratory testing for protein S deficiency: communication from the SSC committee plasma coagulation inhibitors of the ISTH","volume":"19","author":"Marlar","year":"2021","journal-title":"J Thromb Haemostasis"},{"issue":"1","key":"10.1016\/j.mcna.2025.01.008_bib34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jth.14648","article-title":"Recommendations for clinical laboratory testing for antithrombin deficiency; Communication from the SSC of the ISTH","volume":"18","author":"Van Cott","year":"2020","journal-title":"J Thromb Haemostasis"},{"issue":"6","key":"10.1016\/j.mcna.2025.01.008_bib35","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.blre.2017.07.006","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"31","author":"Chaturvedi","year":"2017","journal-title":"Blood Rev"},{"issue":"11","key":"10.1016\/j.mcna.2025.01.008_bib36","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMra1112830","article-title":"The pathogenesis of the antiphospholipid syndrome","volume":"368","author":"Giannakopoulos","year":"2013","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.mcna.2025.01.008_bib37","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies","volume":"7","author":"Meroni","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"10.1016\/j.mcna.2025.01.008_bib38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11926-021-01038-2","article-title":"Epidemiology of antiphospholipid syndrome in the general population","volume":"23","author":"Dabit","year":"2022","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"10.1016\/j.mcna.2025.01.008_bib39","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-0038-1648840","article-title":"Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects","volume":"72","author":"Vila","year":"1994","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.mcna.2025.01.008_bib40","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/jth.14720","article-title":"Prevalence of confirmed antiphospholipid syndrome in 18-50 years unselected patients with first unprovoked venous thromboembolism","volume":"18","author":"Miranda","year":"2020","journal-title":"J Thromb Haemostasis"},{"issue":"10","key":"10.1016\/j.mcna.2025.01.008_bib41","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.42624","article-title":"The 2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"75","author":"Barbhaiya","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.mcna.2025.01.008_bib42","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemostasis"},{"issue":"11","key":"10.1016\/j.mcna.2025.01.008_bib43","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/jth.15047","article-title":"Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation","volume":"18","author":"Devreese","year":"2020","journal-title":"J Thromb Haemostasis"},{"issue":"2","key":"10.1016\/j.mcna.2025.01.008_bib44","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/jth.15585","article-title":"Semiquantitative interpretation of anticardiolipin and anti\u03b22glycoprotein I antibodies measured with various analytical platforms: communication from the ISTH SSC subcommittee on lupus anticoagulant\/antiphospholipid antibodies","volume":"20","author":"Vandevelde","year":"2022","journal-title":"J Thromb Haemostasis"},{"issue":"1","key":"10.1016\/j.mcna.2025.01.008_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/asheducation-2016.1.1","article-title":"Inherited thrombophilia: a double-edged sword","volume":"2016","author":"Middeldorp","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"4","key":"10.1016\/j.mcna.2025.01.008_bib46","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s11239-020-02090-y","article-title":"Thrombophilia screening revisited: an issue of personalized medicine","volume":"49","author":"Colucci","year":"2020","journal-title":"J Thromb Thrombolysis"},{"issue":"8","key":"10.1016\/j.mcna.2025.01.008_bib47","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1055\/s-0040-1712913","article-title":"Venous Thromboembolic diseases: diagnosis, management and thrombophilia testing: observations on NICE Guideline [NG158]","volume":"120","author":"Schulman","year":"2020","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.mcna.2025.01.008_bib48","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11239-015-1316-1","article-title":"Guidance for the evaluation and treatment of hereditary and acquired thrombophilia","volume":"41","author":"Stevens","year":"2016","journal-title":"J Thromb Thrombolysis"},{"issue":"8","key":"10.1016\/j.mcna.2025.01.008_bib49","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/eurjpc\/zwab088","volume":"29","author":"Mazzolai","year":"2021","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"10.1016\/j.mcna.2025.01.008_bib50","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1097\/AOG.0000000000002703","article-title":"Inherited thrombophilias in pregnancy","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.mcna.2025.01.008_bib51","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mcna.2025.01.008_bib52","doi-asserted-by":"crossref","first-page":"e3979","DOI":"10.1136\/bmj.e3979","article-title":"Management of venous thromboembolic diseases and the role of thrombophilia testing: summary of NICE guidance","volume":"344","author":"Chong","year":"2012","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.mcna.2025.01.008_bib53","first-page":"111","article-title":"Prevention and treatment of venous thromboembolism--International Consensus Statement","volume":"32","author":"Nicolaides","year":"2013","journal-title":"Int Angiol"},{"issue":"1","key":"10.1016\/j.mcna.2025.01.008_bib54","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s11239-019-01930-w","article-title":"Appropriateness of thrombophilia testing in patients in the acute care setting and an evaluation of the associated costs","volume":"49","author":"Virparia","year":"2020","journal-title":"J Thromb Thrombolysis"},{"issue":"3","key":"10.1016\/j.mcna.2025.01.008_bib55","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1055\/s-0040-1714334","article-title":"Clinical utilization and cost of thrombophilia testing in patients with venous thromboembolism","volume":"4","author":"Gaddh","year":"2020","journal-title":"TH Open"},{"issue":"13","key":"10.1016\/j.mcna.2025.01.008_bib56","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1182\/bloodadvances.2024012931","article-title":"Decision theoretical foundations of clinical practice guidelines: an extension of the ASH thrombophilia guidelines","volume":"8","author":"Djulbegovic","year":"2024","journal-title":"Blood Advances"},{"key":"10.1016\/j.mcna.2025.01.008_bib57","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejim.2015.12.010","article-title":"A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES)","volume":"29","author":"Franco Moreno","year":"2016","journal-title":"Eur J Intern Med"},{"issue":"14","key":"10.1016\/j.mcna.2025.01.008_bib58","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.109.925214","article-title":"Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model","volume":"121","author":"Eichinger","year":"2010","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.mcna.2025.01.008_bib59","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1503\/cmaj.080493","article-title":"Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy","volume":"179","author":"Rodger","year":"2008","journal-title":"CMAJ (Can Med Assoc J)"},{"issue":"8","key":"10.1016\/j.mcna.2025.01.008_bib60","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3324\/haematol.10234","article-title":"The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies","volume":"92","author":"Marchiori","year":"2007","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.mcna.2025.01.008_bib61","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archinte.166.7.729","article-title":"Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review","volume":"166","author":"Ho","year":"2006","journal-title":"Arch Intern Med"},{"issue":"19","key":"10.1016\/j.mcna.2025.01.008_bib62","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.mcna.2025.01.008_bib63","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1160\/TH08-06-0364","article-title":"High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin","volume":"101","author":"Brouwer","year":"2009","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.mcna.2025.01.008_bib64","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/jth.13960","article-title":"Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow-up study","volume":"16","author":"Sokol","year":"2018","journal-title":"J Thromb Haemostasis"},{"issue":"5","key":"10.1016\/j.mcna.2025.01.008_bib65","first-page":"695","article-title":"The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S","volume":"91","author":"De Stefano","year":"2006","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.mcna.2025.01.008_bib66","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0038-1625983","article-title":"Risk of venous thrombosis in antithrombin deficiency: a systematic review and bayesian meta-analysis","volume":"44","author":"Croles","year":"2018","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"10.1016\/j.mcna.2025.01.008_bib67","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.mcna.2025.01.008_bib68","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"23","key":"10.1016\/j.mcna.2025.01.008_bib69","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1161\/CIRCULATIONAHA.118.036548","article-title":"Let\u2019s stop dichotomizing venous thromboembolism as provoked or unprovoked","volume":"138","author":"Albertsen","year":"2018","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.mcna.2025.01.008_bib70","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1182\/bloodadvances.2018017160","article-title":"Risk of recurrent venous thromboembolism according to baseline risk factor profiles","volume":"2","author":"Prins","year":"2018","journal-title":"Blood Adv"},{"issue":"Si","key":"10.1016\/j.mcna.2025.01.008_bib71","doi-asserted-by":"crossref","first-page":"Si37","DOI":"10.1093\/rheumatology\/kead675","article-title":"Viewpoint: provoked thrombosis in antiphospholipid syndrome","volume":"63","author":"Wahl","year":"2024","journal-title":"Rheumatology"},{"issue":"2\u20133","key":"10.1016\/j.mcna.2025.01.008_bib72","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12026-013-8407-x","article-title":"Discontinuation of anticoagulation or antiaggregation treatment may be safe in patients with primary antiphospholipid syndrome when antiphospholipid antibodies became persistently negative","volume":"56","author":"Coloma Baz\u00e1n","year":"2013","journal-title":"Immunol Res"},{"issue":"4","key":"10.1016\/j.mcna.2025.01.008_bib73","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/jth.14398","article-title":"Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis","volume":"17","author":"Elsebaie","year":"2019","journal-title":"J Thromb Haemostasis"},{"issue":"9","key":"10.1016\/j.mcna.2025.01.008_bib74","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1111\/jth.14935","article-title":"Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: guidance from the scientific and standardization committee of the international society on thrombosis and haemostasis","volume":"18","author":"Zuily","year":"2020","journal-title":"J Thromb Haemostasis"},{"issue":"1","key":"10.1016\/j.mcna.2025.01.008_bib75","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jacc.2022.10.008","article-title":"Direct oral anticoagulants vs vitamin K antagonists in patients with antiphospholipid syndromes: meta-analysis of randomized trials","volume":"81","author":"Khairani","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.mcna.2025.01.008_bib76","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood-2018-04-848333","article-title":"Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome","volume":"132","author":"Pengo","year":"2018","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.mcna.2025.01.008_bib77","doi-asserted-by":"crossref","first-page":"102468","DOI":"10.1016\/j.rpth.2024.102468","article-title":"Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trial","volume":"8","author":"Mittal","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"1","key":"10.1016\/j.mcna.2025.01.008_bib78","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1182\/hematology.2021000291","article-title":"Prevention and management of venous thromboembolism in pregnancy: cutting through the practice variation","volume":"2021","author":"Skeith","year":"2021","journal-title":"Hematology"},{"issue":"10395","key":"10.1016\/j.mcna.2025.01.008_bib79","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0140-6736(23)00693-1","article-title":"Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial","volume":"402","author":"Quenby","year":"2023","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.mcna.2025.01.008_bib80","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/humrep\/deab010","article-title":"Hereditary thrombophilia and recurrent pregnancy loss: a systematic review and meta-analysis","volume":"36","author":"Liu","year":"2021","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.mcna.2025.01.008_bib81","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1182\/asheducation-2014.1.387","article-title":"Pregnancy and venous thromboembolism: \u2018TIPPS\u2019 for risk stratification","volume":"2014","author":"Rodger","year":"2014","journal-title":"Hematology"},{"issue":"9955","key":"10.1016\/j.mcna.2025.01.008_bib82","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(14)60793-5","article-title":"Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial","volume":"384","author":"Rodger","year":"2014","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.mcna.2025.01.008_bib83","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy","volume":"2","author":"Bates","year":"2018","journal-title":"Blood Advances"},{"issue":"19","key":"10.1016\/j.mcna.2025.01.008_bib84","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1182\/blood-2016-03-703728","article-title":"Hereditary risk factors for thrombophilia and probability of venous thromboembolism during pregnancy and the puerperium","volume":"128","author":"Gerhardt","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.mcna.2025.01.008_bib85","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/AOG.0000000000001347","article-title":"Pregnancy-related venous thromboembolism risk in asymptomatic women with antithrombin deficiency: a systematic review","volume":"127","author":"Rh\u00e9aume","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.mcna.2025.01.008_bib86","first-page":"809","article-title":"Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism","volume":"86","author":"Emmerich","year":"2001","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1016\/j.mcna.2025.01.008_bib87","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1182\/blood.V85.10.2756.bloodjournal85102756","article-title":"Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study)","volume":"85","author":"Koster","year":"1995","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.mcna.2025.01.008_bib88","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.thromres.2015.03.010","article-title":"Natural anticoagulants deficiency and the risk of venous thromboembolism: a meta-analysis of observational studies","volume":"135","author":"Di Minno","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.mcna.2025.01.008_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.883986","article-title":"Current knowledge on factor V leiden mutation as a risk factor for recurrent venous thromboembolism: a systematic review and meta-analysis","volume":"9","author":"Eppenberger","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.mcna.2025.01.008_bib90","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1182\/blood-2013-04-496257","article-title":"Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review","volume":"122","author":"Garcia","year":"2013","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.mcna.2025.01.008_bib91","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM199909093411104","article-title":"The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation","volume":"341","author":"De Stefano","year":"1999","journal-title":"N Engl J Med"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712525000203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712525000203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T21:11:15Z","timestamp":1749503475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712525000203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":91,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0025712525000203"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2025.01.008","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombophilia Testing in Venous Thromboembolism","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2025.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}